Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877017 · ClinicalTrials.gov registry record · NA
Family Activation and Communication About Errors and Safety (FACES)
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 985
- Enrollment target
NCT02877017: Completed NA study, sponsored by Boston Children's Hospital.
NCT02877017 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 985 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877017, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 985 participants
- Enrollment target
Study Summary
Miscommunications are a leading cause of serious medical errors in hospitals, contributing to more than 60% of sentinel events, the most serious adverse events reported to the Joint Commission. Efforts to improve patient safety in hospitals have centered on improving communication between providers. While provider-focused communication interventions have led to reductions in patient harm, patients and families have been notably absent from most interventions to improve patient safety. This proposal seeks to develop a family safety reporting intervention.
Primary Outcome
Our primary outcome was family-reported safety concerns, defined as reporting safety concern(s) via pre-discharge survey (baseline and intervention) or mobile tool (intervention). Safety concerns were counted once if reported both via survey and mobile tool.
Interventions
- BEHAVIORAL Family safety reporting intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 985 participants |
| Start Date | 2018-04-05 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT02877017 record still lists
NCT02877017 is an interventional study that assigns participants to a tested intervention. The registered 985 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 1 intervention - of which Family safety reporting intervention is the first listed.
NCT02877017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02877017 about?
NCT02877017 is a clinical study titled "Family Activation and Communication About Errors and Safety (FACES)". Miscommunications are a leading cause of serious medical errors in hospitals, contributing to more than 60% of sentinel events, the most serious adverse events reported to the Joint Commission. Efforts to improve patient safety in hospitals have centered on improving communication between providers....
What is the current status of trial NCT02877017?
This trial is currently completed. It is a NA study. The enrollment target is 985 participants. The study started on 2018-04-05. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT02877017?
The interventions under investigation include: Family safety reporting intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02877017?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02877017's enrollment target sits among peer trials
985 122nd of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI